enGene Therapeutics (ENGN) Treasury Shares (2022 - 2023)

enGene Therapeutics (ENGN) has 2 years of Treasury Shares data on file, last reported at $5.6 million in Q3 2023.

• For the quarter ending Q3 2023, Treasury Shares changed N/A year-over-year to $5.6 million; the trailing twelve-month figure through Jul 2023 stood at $5.6 million (changed N/A YoY), and the FY2022 full-year result was $5.6 million, changed N/A from the prior year.
• Treasury Shares was $5.6 million for Q3 2023 at enGene Therapeutics, roughly flat from $5.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.6 million in Q4 2022 to a low of $5.6 million in Q4 2022.